Stocksigma LogoStocksigma Logo

Sudarshan Pharma Board Approves Issuance of 72 Crore Convertible Warrants to Promoters

Sudarshan Pharma Industries' board approved raising funds via the preferential issuance and allotment of up to 72 crore convertible warrants to promoters

Sudarshan Pharma Board Approves Issuance of 72 Crore Convertible Warrants to Promoters

Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 30 Oct 2026, 8:35 pm

Sudarshan Pharma Board Approves Issuance of 72 Crore Convertible Warrants to Promoters Sudarshan Pharma Industries' board approved raising funds via the preferential issuance and allotment of up to 72 crore convertible warrants to promoters Hemal Mehta and Sachin Mehta on 29th Oct'26. Each warrant is convertible into one equity share of face value Re 1. The issue price will be determined in accordance with SEBI ICDR Regulations. The transaction remains subject to statutory, regulatory, and shareholder approvals at an upcoming Extraordinary General Meeting.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements